Stem cells market is expected to grow at a CAGR of 21.8% during the forecast period (2018-2023). Stem cell are undifferentiated cells which have the capability of multiplying in multiple number of cells. Stem cells market are of two types- adult stem cells and embryonic stem cells. Stem cells are being studied for their unique regenerative properties. They are being used in drug discovery programs to develop new drugs and treatment methods. Stem cell research .
is also being used to study genetic disorders, birth defects and other growth factors. Stem cell banks are being established which store stem cells and umbilical cord blood containing stem cells. These are used for treating the individual in future. Stem cell banking is gaining popularity amongst modern day parents who opt to store their new-born’s cells to prevent any future ailments. Stem cell are being used to treat and diagnose cancer. These cells are significant part of understanding and treating cancer; especially in children.
Stem cell technology is being funded by governments, NGO’s and private firms considering the potential it has in changing the shape of healthcare. New gene editing technologies such as CRISPR is also going to boost the stem cell research and market could witness influx of a number of products. The market is segmented on the basis of products, technology and application. Factors that are motivating the market are innovations and development of new products, growing number of stem cell banks and increasing research in paediatrics. Additionally, rising popularity due to increased research specially in the field of oncology is also motivating the market. However, there are some restrain in the stem cell market such as long approval processes and tough clinical trial regulations, high cost of therapeutic applications, and high cost of stem cell research. Due to this, the research and technology development is limited to financial support from governments.
For related reports: Biotechnology industry
Geographically, North America and Europe contribute around 70% in the total stem cell market. North American and European companies get significant support through funding and investment from government and private players. More number of start-ups and universities are also contributing in these regions and creating considerable scope for global stem cell market. These companies are also attracting a lot of investment. Asia Pacific market is expected to grow at a healthy growth rate during the forecast period 2018-2023. Asia Pacific region gets significant contribution from Japan, China, India and South Korea. Considerable R&D exploration, growing investment and improving healthcare infrastructure creates significant scope for stem cell market in APAC region. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market determinants, key company analysis, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
The key players of global stem cell market include StemCells, Inc., U.S. Stem Cell, Inc., Apceth GmbH und Co. KG and Osiris Therapeutics, Inc. Other companies profiled in the report include AlloSource, Inc, BioTime, Inc., Cell Cure Neurosciences Ltd., Mesoblast Ltd, NeoStem Oncology, LLC, Pluristem Therapeutics Inc., Reliance Life Sciences Pvt. Ltd., ReNeuron Group plc and RTI Surgical, Inc. M&A, product expansion, product launch and partnership are the key strategy adopted in the global Stem cell market. Global Stem cell market players are constantly focusing on expansion, product launch, R&D, innovation and technological advancement. Rising competition makes global Stem cell market dynamic and fast growing.
Research methods and tools
The market study of stem cell has been incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analysing various regional players, regional tax laws and policies, consumer behaviour and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include
Financial/annual reports of companies involved in the market
Forward looking statement of key stem cell market players
Authentic Public Databases
Whitepapers, research-papers and news blogs
Company websites and their product catalogue.
Per capita healthcare expenditure
Government funding for the research and development activities
The report is intended for global stem cell market players, potential entrants, diagnostic laboratories, healthcare provider, universities for overall market insights. The report provides in-depth analysis on pricing, market size, market determinants and competitive landscape. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis delivering insights into the market for better business decisions.
Global Stem Cells Market Research and Analysis, By product
Global Stem Cells Market Research and Analysis, Technology
Global Stem Cells Market Research and Analysis, By Application
Global Stem Cells Market Research and Analysis, By Region
THE REPORT COVERS
Comprehensive research methodology of Global Stem Cell Market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Stem Cell Market.
Insights about market determinants which are stimulating the Global Stem Cell Market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.Companies Mentioned
1. ALLOSOURCE, INC.
2. ANTEROGEN CO., LTD.
3. APCETH GMBH UND CO. KG
4. BIOTIME, INC.
5. CELL CURE NEUROSCIENCES LTD.
6. GAMIDA CELL LTD.
7. MEDIPOST CO., LTD.
8. MESOBLAST LTD
9. NEOSTEM ONCOLOGY, LLC
10. NEURALSTEM, INC.
11. NUVASIVE, INC.
12. OCATA THERAPEUTICS, INC.
13. ORTHOCYTE CORPORATION
14. ORTHOFIX INC.
15. OSIRIS THERAPEUTICS, INC.
16. PHARMICELL CO., LTD.
17. PLURISTEM THERAPEUTICS INC.
18. RELIANCE LIFE SCIENCES PVT. LTD.
19. RENEURON GROUP PLC
20. RTI SURGICAL, INC.
21. STEMCELLS, INC.
22. STEMPEUTICS RESEARCH PVT. LTD.
23. U.S. STEM CELL, INC. (BIOHEART)
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)